Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001959669 | SCV002247969 | uncertain significance | Distal hereditary motor neuropathy type 2 | 2021-06-20 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Tyr158*) in the FBXO38 gene. It is expected to result in an absent or disrupted protein product. However, the current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in FBXO38 cause disease. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant has not been reported in the literature in individuals with FBXO38-related conditions. This variant is not present in population databases (ExAC no frequency). |